Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy-Reference-Cited by-同舟云学术

Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy

Published:2019-01-15 Issue:1 Volume:51 Page:368-377
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Zhang Ya-Ping,Zhang Run,Zhu Hua-Yuan,Wang Li,Wu Yu-Jie,Liang Jin-Hua,Shi Wen-Yu,Liu Hong,Xu Wei,Li Jian-Yong

Funder

National Natural Science Foundation of China

Jiangsu Province’s Medical Elite Programme

National Science & Technology Pillar Program

Jiangsu Provincial Special Program of Medical Science

National Science and Technology Major Project

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-010.pdf

Reference27 articles.

1. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution

2. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

3. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project

4. Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of pre-treatment T lymphocyte subsets in patients with extranodal natural killer/T-cell lymphoma;Annals of Hematology;2024-08-28

2. Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma;Aging;2022-11-16

3. Low absolute CD4+ T cell counts in peripheral blood: an independent predictor of inferior survival in natural killer/T-cell lymphoma—a retrospective cohort study;Annals of Translational Medicine;2022-10

4. Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma;Life;2021-08-16

5. An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy;Frontiers in Oncology;2021-07-13